Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-006960
Filing Date
2025-05-08
Accepted
2025-05-08 16:03:27
Documents
106
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q coll-20250331x10q.htm   iXBRL 10-Q 2033125
2 EX-10.1 coll-20250331xex10d1.htm EX-10.1 116488
3 EX-31.1 coll-20250331xex31d1.htm EX-31.1 12971
4 EX-31.2 coll-20250331xex31d2.htm EX-31.2 12998
5 EX-32.1 coll-20250331xex32d1.htm EX-32.1 7550
6 EX-32.2 coll-20250331xex32d2.htm EX-32.2 7391
7 GRAPHIC coll-20250331x10q001.jpg GRAPHIC 9164
  Complete submission text file 0001558370-25-006960.txt   11136084

Data Files

Seq Description Document Type Size
8 EX-101.SCH coll-20250331.xsd EX-101.SCH 81934
9 EX-101.CAL coll-20250331_cal.xml EX-101.CAL 111893
10 EX-101.DEF coll-20250331_def.xml EX-101.DEF 321077
11 EX-101.LAB coll-20250331_lab.xml EX-101.LAB 635312
12 EX-101.PRE coll-20250331_pre.xml EX-101.PRE 513024
109 EXTRACTED XBRL INSTANCE DOCUMENT coll-20250331x10q_htm.xml XML 2178008
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37372 | Film No.: 25925866
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)